AGI Therapeutics, the drug firm run by former Elan executives, will float on the Alternative Investment Market on February 27, raising stg£29.2 million (€42.7 million).
The company is confident of raising more than its initial target of €35 million after strong demand for its shares at investor roadshows. AGI, which is less than three years old, is likely to be valued at over €120 million in the flotation.
AGI’s biggest individual shareholder is co-founder and...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team